Conclusion
This study established that a 4-day pulsed high dose schedule AZD8931 of 160 mg bd is safe and sufficiently tolerated when combined with FOLFIRI. Further studies of TKI sequencing may establish a role for pulsed use of such agents rather than continuous exposure.